United Kingdom· GB-APID-11527211000001100
Cabergoline 1mg tablets
A cabergoline product containing cabergoline, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Cabergoline is registered in 8 of 19 countries.
Countries holding a registration under ATC N04BC06 (cabergoline), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Cabergoline · ATC N04BC06
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cabergoline costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cabergoline · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- FR France$20.42
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Cabergoline
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- N04BC06
- ATC class
- Cabergoline
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5025903006800
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for cabergoline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cabergoline · interactions on record
65 records
- 3 severe
- 17 moderate
- 45 info
Most severe, free to view
- LorcaserinA08AA11severe
- ErythromycinJ01FA01severe
- ClarithromycinJ01FA09severe
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cabergoline in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCabergoline Hexal 1 mg TablettHexal A/S
- SpainCABERGOLINA TEVA 1 mg COMPRIMIDOS EFGTeva Pharma S.L.U.
- FinlandCabaserPfizer Oy
- IrelandCabaser 1 mg TabletPfizer Healthcare Ireland Unlimited Company
- SwitzerlandCabaser 1 mg, TablettenPfizer AG
- PolandDostinexPretium Farm Sp. z o.o.
- United StatesCabergolineA-S Medication Solutions
- GermanyCabaserilPfizer Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Cabaseril, Dostinex
- Belgium · Cabergoline Teva, Dostinex
- Bulgaria · Достинекс
- Cyprus · Dostinex
- Czechia · Dostinex
- Germany · Cabaseril, Cabergoletten
- Denmark · Cabenex, Cabergolin Teva
- Spain · Cabergolina Teva, Dostinex
- Finland · Cabaser, Dostinex
- France · Cabergoline Arrow, Cabergoline Biogaran
- Greece · Dostinex
- Croatia · Dostinex
- Ireland · Cabaser, Cabergoline Renata Pharmaceuticals (Ireland)
- Iceland · Dostinex
- Italy · Cabaser, Cabergolina Aurobindo
- Luxembourg · Cabergoline Teva, Dostinex
- Latvia · Dostinex
- Malta · Cabergoline Aurobindo, Cabergoline Doc
- Netherlands · Cabergoline Aurobindo, Cabergoline Pch
- Norway · Cabergoline Renata Pharmaceuticals (Ireland), Dostinex
- Poland · Dostinex
- Portugal · Cabergolina Generis, Cabergoline 0.5 Mg Tablets
- Romania · Dostinex
- Sweden · Cabenex, Cabergoline Ratiopharm
- Slovakia · Cabest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f58bee66-d73e-46d8-aaee-7d984f44308e GET /v1/drugs/f58bee66-d73e-46d8-aaee-7d984f44308e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "11527211000001100",
"desc": "Cabergoline 1mg tablets (A A H Pharmaceuticals Ltd)",
"form": "Oral tablet",
"vpid": "41872211000001100",
"source": "dmd",
"vtm_id": "774961008",
"strength": "1 mg",
"substance": "Cabergoline",
"ingredient": "Cabergoline",
"supplier_code": "3144701000001104"
}See everything about cabergoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.